Synvitta Diagnostics Announces Bold Mission To Advance Multiplex Diagnostic Testing (Alachua Chronicle)
UF Innovate | Accelerate resident client Synvitta Diagnostics, Inc., a biotechnology company developing next-generation diagnostic solutions, announced a strategic partnership between Mitch Glaeser, Co-Founder and Chief Executive Officer, and Rainara Almeida, M.Sc., Co-Founder and Chief Scientific Officer.
NeXtGen™ Biologics Secures Favorable Outcome in Inter-Partes Patent Review (BioSpace)
UF Innovate | Accelerate resident client NeXtGen Biologics reported that the U.S. Patent and Trademark Office declined to initiate an inter partes review of its wound care patents, leaving the intellectual property fully enforceable.
NeXtGen Biologics and Lovell Government Services Partner To Bring Innovative Advanced Wound Care Technology to Federal Healthcare Systems (Globe Newswire)
UF Innovate | Accelerate resident client NeXtGen™ Biologics has partnered with Lovell® Government Services to expand access to its advanced wound care technologies across federal healthcare systems, including the Veterans Health Administration (VHA), the Military Health System (MHS), and the Indian Health Service (IHS).
NeXtGen Biologics Successfully Completes First FDA Audit With Zero 483 Observations (Globe Newswire)
UF Innovate | Accelerate resident client NeXtGen Biologics announced the successful completion of a two-day inspection by the U.S. Food and Drug Administration (FDA).
NeXtGen Biologics Announces Issuance of a Third New Patent Covering Axolotl-Derived Technology (Globe Newswire)
UF Innovate | Accelerate resident client NeXtGen Biologics has announced the issuance of its third U.S. patent, part of a broader portfolio of U.S. and international patents focused on extracellular matrix components derived from a highly regenerative, non-mammalian species known as the axolotl, a type of urodele amphibian.
Tech Tuesday: University of Florida Lab Diagnoses and Removes Viruses Through Genome Editing (WCJB TV20)
In this week’s Tech Tuesday, UF Innovate highlights CasNx, a company that uses CRISPR-based technologies for diagnostics and to genome-edit donor organs before transplant.
Nasser Nassiri Koopaei Is on a Mission to Address Unmet Medical Needs With His Biotechnology Startup (UF Pharmacy)
UF researcher Nasser Nassiri Koopaei has been working to transform his research on stem cell-derived extracellular vesicles for targeted drug delivery through his biotechnology startup, EriVan Bio, a UF startup.
Alchem Laboratories and Applied Pharmaceutical Innovation Forge Strategic Alliance to Advance Antimicrobial Programs (Newswires)
UF Innovate | Accelerate client company Alchem Laboratories and Applied Pharmaceutical Innovation announced the formation of a strategic alliance to explore and advance joint initiatives in the fields of antimicrobials and essential medicine therapeutics, improving supply chain resiliency.
UF Innovate Awarded Top Entrepreneurship Honors at International Conference
The University of Florida’s start-up incubator, UF Innovate, further solidified its Accelerator program as among the industry’s best after earning top awards at the 2025 International Business Innovation Association’s annual conference in Philadelphia.
DiaCarta Reports Positive Clinical Trial Data for Its Blood Based Test To Triage FIT-Positive Patients Enrolled in CRC Screening Programs
UF Innovate | Sid Martin Biotech alum DiaCarta Inc. has announced the publication of its prospective clinical trial data on its blood-based test for triaging FIT (fecal immunochemical test)-positive patients in colorectal cancer (CRC) screening.